Nemifitide
Title: Nemifitide
CAS Registry Number: 173240-15-8
CAS Name: 4-Fluoro-L-phenylalanyl-(4R)-4-hydroxy-L-prolyl-L-arginylglycyl-L-tryptophanamide
Additional Names: 4-F-Phe-4-OH-Pro-Arg-Gly-Trp-NH2; netamifide
Molecular Formula: C33H43FN10O6
Molecular Weight: 694.76
Percent Composition: C 57.05%, H 6.24%, F 2.73%, N 20.16%, O 13.82%
Literature References: Synthetic pentapeptide produced by modification of melanocyte stimulating inhibitory factor. Prepn: H. B. Abajian, et al., WO 9530430; eidem, US 5589460 (1995, 1996 both to Innapharma). Structure activity study: J. J. Hlavka, J. Appl. Res. 2, 58 (2002). Clinical pharmacokinetics: J. P. Feighner et al., Biopharm. Drug Dispos. 23, 33 (2002); G. Nicolau et al., ibid. 26, 379 (2005). Clinical evaluation: eidem, Int. J. Neuropsychopharm. 6, 207 (2003). Review of development and therapeutic potential: J. Dingemanse, Curr. Opin. Invest. Drugs 4, 859-862 (2003).
 
Derivative Type: Bis(trifluoroacetate)
CAS Registry Number: 204992-09-6
Additional Names: Nemifitide ditriflutate
Manufacturers' Codes: INN-00835
Molecular Formula: C33H43FN10O6.2C2HF3O2
Molecular Weight: 922.80
Percent Composition: C 48.16%, H 4.92%, F 14.41%, N 15.18%, O 17.34%
 
Therap-Cat: Antidepressant.
Keywords: Antidepressant.

Others monographs:
Samarium IodideGeissospermineEpothilonesNocardicin(s)
Gold MonocyanideTungsten TrioxidePerbenzoic AcidCalcium Stearate
ApalcillinPyrethrosinFloxuridineBarium Titanate(IV)
ChymotrypsinsEtanidazoleTroclosene Potassiumm-Tyrosine
©2016 DrugLead US FDA&EMEA